{"success":true,"data":{"pressRelease":{"id":"170638","rtpr_id":"nGNX8pNM44-20261015","ticker":"HIMS","exchange":"NYSE","all_tickers":["HIMS"],"title":"HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law ","author":"Globe Newswire","published_at":"2026-10-15T14:15:13.094Z","article_body":"LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP\n(https://www.globenewswire.com/Tracker?data=J9Z_Dv9vm5Fc4PGoh0cmFKywIrtF4mGGLiUAVeMjHIPFaSJC2wFcrs9LaPxcWRvO_-45D1uB2B9GjmM19BFW4NLHzUB1SBSY3KCG7399flUk6s-h4EaxetT36TzM0eWW)\n(“SBS”), a national shareholder rights litigation firm, reminds investors\nof a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers”\nor “the Company”) (NYSE: HIMS\n(https://www.globenewswire.com/Tracker?data=5lWQWIxoZCOsfIk07Q2co86T0fHhEeEjwfQDKmeODfKDcT2NB_8g1FN_ZmahNlOw6ZXAZ-yARPi15b6-GxMy9suHJgLo7rcFTgrPcliU8Lc=))\nfor violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934\nand Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of HIMS during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: August 4, 2025 to July 29, 2026\n\nDEADLINE: November 2, 2026\n\nIf you are a shareholder who suffered a loss, click here to participate\n(https://www.globenewswire.com/Tracker?data=leUCissE_-8ZaViyq_D9cskWC5ecSntfDdZ1JekflKTAM21FCcNXNe0Fpwiv6H_owoA63uVX5Y1mEA_abudHAnoyoOxkFUrMkYGkaBA26wMD2ik8upN8BvesD1fnQU8GRV_NYqLa7xhQSLV4C05ADw==).\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Hims & Hers provided customer health data\nto third-party advertising platforms. The Company’s treatment practices were\nlikely to result in heightened regulatory scrutiny. Based on these facts, the\nCompany’s public statements were false and materially misleading throughout\nthe class period. When the market learned the truth about Hims & Hers,\ninvestors suffered damages.\n\nWe also encourage you to contact Brian Schall or David Schwartz of Schall,\nBrown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA\n90067, at 310-301-3335, to discuss your rights free of charge. You can also\nreach us through the firm's website at www.schallfirm.com, or by email\nat david@schallfirm.com.\n\nThe class, in this case, has not yet been certified, and until certification\noccurs, you are not represented by an attorney. If you choose to take no\naction, you can remain an absent class member.\n\nJoin the case\n(https://www.globenewswire.com/Tracker?data=Y4pSPPs0uWw7xGVyY6wyfdJ6ODIZcVQu9g1Hc6E27cYUcJazJ8nQ2sXI9Z4UeFLY1xV9CKIts9C-H3xXFTdvvRnDiC4sKL1ZaTvYnvV_WQ5Um9naY7-XarIh9cy_AcvX)\nto recover your losses\n\nWHY SBS? Schall, Brown & Schwartz LLP represents investors around the world\nand specializes in securities class action lawsuits and shareholder rights\nlitigation. Bringing together the extensive experience and diverse skillsets\nof founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is\ndedicated to aggressively advocating for every investor.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.        \n\nCONTACT:\n\nSchall, Brown & Schwartz LLP\nBrian Schall, Esq.,\nAndrew Brown, Esq.,\nDavid Schwartz, Esq.,\nwww.schallfirm.com\nOffice: 310-301-3335\ninfo@schallfirm.com\n\nSOURCE:\n\nSchall, Brown & Schwartz LLP\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0b1ae5f6-3843-4b48-9c73-0b3760ba856a)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8pNM44-20261015","title":"HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law ","author":"Globe Newswire","ticker":"HIMS","created":"2026-10-15T14:15:13.094Z","tickers":["HIMS"],"exchange":"NYSE","article_body":"LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP\n(https://www.globenewswire.com/Tracker?data=J9Z_Dv9vm5Fc4PGoh0cmFKywIrtF4mGGLiUAVeMjHIPFaSJC2wFcrs9LaPxcWRvO_-45D1uB2B9GjmM19BFW4NLHzUB1SBSY3KCG7399flUk6s-h4EaxetT36TzM0eWW)\n(“SBS”), a national shareholder rights litigation firm, reminds investors\nof a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers”\nor “the Company”) (NYSE: HIMS\n(https://www.globenewswire.com/Tracker?data=5lWQWIxoZCOsfIk07Q2co86T0fHhEeEjwfQDKmeODfKDcT2NB_8g1FN_ZmahNlOw6ZXAZ-yARPi15b6-GxMy9suHJgLo7rcFTgrPcliU8Lc=))\nfor violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934\nand Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of HIMS during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: August 4, 2025 to July 29, 2026\n\nDEADLINE: November 2, 2026\n\nIf you are a shareholder who suffered a loss, click here to participate\n(https://www.globenewswire.com/Tracker?data=leUCissE_-8ZaViyq_D9cskWC5ecSntfDdZ1JekflKTAM21FCcNXNe0Fpwiv6H_owoA63uVX5Y1mEA_abudHAnoyoOxkFUrMkYGkaBA26wMD2ik8upN8BvesD1fnQU8GRV_NYqLa7xhQSLV4C05ADw==).\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Hims & Hers provided customer health data\nto third-party advertising platforms. The Company’s treatment practices were\nlikely to result in heightened regulatory scrutiny. Based on these facts, the\nCompany’s public statements were false and materially misleading throughout\nthe class period. When the market learned the truth about Hims & Hers,\ninvestors suffered damages.\n\nWe also encourage you to contact Brian Schall or David Schwartz of Schall,\nBrown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA\n90067, at 310-301-3335, to discuss your rights free of charge. You can also\nreach us through the firm's website at www.schallfirm.com, or by email\nat david@schallfirm.com.\n\nThe class, in this case, has not yet been certified, and until certification\noccurs, you are not represented by an attorney. If you choose to take no\naction, you can remain an absent class member.\n\nJoin the case\n(https://www.globenewswire.com/Tracker?data=Y4pSPPs0uWw7xGVyY6wyfdJ6ODIZcVQu9g1Hc6E27cYUcJazJ8nQ2sXI9Z4UeFLY1xV9CKIts9C-H3xXFTdvvRnDiC4sKL1ZaTvYnvV_WQ5Um9naY7-XarIh9cy_AcvX)\nto recover your losses\n\nWHY SBS? Schall, Brown & Schwartz LLP represents investors around the world\nand specializes in securities class action lawsuits and shareholder rights\nlitigation. Bringing together the extensive experience and diverse skillsets\nof founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is\ndedicated to aggressively advocating for every investor.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.        \n\nCONTACT:\n\nSchall, Brown & Schwartz LLP\nBrian Schall, Esq.,\nAndrew Brown, Esq.,\nDavid Schwartz, Esq.,\nwww.schallfirm.com\nOffice: 310-301-3335\ninfo@schallfirm.com\n\nSOURCE:\n\nSchall, Brown & Schwartz LLP\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0b1ae5f6-3843-4b48-9c73-0b3760ba856a)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-15T14:15:13.133092542Z","server_sent_at_ms":1792073713133},"received_at":"2026-10-15T14:15:13.183Z","source_url":null},"analysis":{"id":"158819","press_release_id":"170638","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":["unsealed class-action complaint alleges HIMS shared customer health data with third-party ad platforms, a potential privacy/regulatory exposure"],"eventType":"legal_litigation","narrative":"Schall, Brown & Schwartz LLP issued a solicitation reminding HIMS investors of a securities fraud class action covering a class period of August 4, 2025 through July 29, 2026, with a November 2, 2026 lead plaintiff deadline.\n\nThe complaint alleges Hims & Hers shared customer health data with third-party advertising platforms and made misleading statements that invited heightened regulatory scrutiny.\n\nThis is law-firm marketing rather than an issuer disclosure; the class has not been certified and no new company information was released.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress, though the health-data privacy allegations merit monitoring for a regulatory angle."},"keyFigures":{},"quotedText":"Hims & Hers provided customer health data to third-party advertising platforms.","namedEntities":{"people":[{"name":"Brian Schall","role":"founding partner, plaintiff law firm"},{"name":"David Schwartz","role":"founding partner, plaintiff law firm"},{"name":"Andrew Brown","role":"founding partner, plaintiff law firm"}],"products":[],"companies":[{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"issuer targeted by securities class action"},{"name":"Schall, Brown & Schwartz LLP","relationship":"plaintiff law firm issuing solicitation"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation issued by Schall, Brown & Schwartz LLP seeking lead plaintiffs in a securities class action against HIMS. No certified class, no settlement, and no new issuer disclosure; the underlying fraud allegations (customer health data shared with ad platforms) are the only substantive content."},"tickerRelevance":{"others":[],"primary":"HIMS"},"globalImportance":15,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap retail favorite","eventGravity":"law-firm-solicitation","issuerAuthored":false,"underlyingAllegation":"customer health data / privacy regulatory risk"}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Schall, Brown & Schwartz LLP issued a solicitation reminding HIMS investors of a securities fraud class action covering a class period of August 4, 2025 through July 29, 2026, with a November 2, 2026 lead plaintiff deadline.\n\nThe complaint alleges Hims & Hers shared customer health data with third-party advertising platforms and made misleading statements that invited heightened regulatory scrutiny.\n\nThis is law-firm marketing rather than an issuer disclosure; the class has not been certified and no new company information was released.","key_figures":{},"named_entities":{"people":[{"name":"Brian Schall","role":"founding partner, plaintiff law firm"},{"name":"David Schwartz","role":"founding partner, plaintiff law firm"},{"name":"Andrew Brown","role":"founding partner, plaintiff law firm"}],"products":[],"companies":[{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"issuer targeted by securities class action"},{"name":"Schall, Brown & Schwartz LLP","relationship":"plaintiff law firm issuing solicitation"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-15T14:15:17.653Z","global_importance":15,"audience_relevance":30,"importance_components":{"tickerTier":"mid-cap retail favorite","eventGravity":"law-firm-solicitation","issuerAuthored":false,"underlyingAllegation":"customer health data / privacy regulatory risk"}},"durationMs":4426,"modelName":"glm-5.3-flashx"}}